Prosiectau (583)
Cardiff University Schools involved in this Project
Investigation of insulin receptor substrate-1 (IRS-1) as a signalling intermediate for erbB receptors in breast cancer (01.02.2008 - 31.01.2011)
- Hutcheson, Iain
Access to Phrmy labs (01.04.2008 - 31.10.2011)
Development of CYP26 inhibitors as neuroblastoma therapeutics (01.07.2008 - 31.03.2011)
- Simons, Claire
Understanding the interactions of oxidising agents with macromolecules and microbial cell components (01.07.2008 - 01.07.2011)
- Maillard, Jean-Yves
Serotonin associated injury and survival signalling in myocardium: Receptor dependant and non receptor targets for cytoprotection (01.09.2008 - 18.11.2012)
- Baxter, Gary
Studies on the exacerbation of pulmonary inflammation by viral infection (01.09.2008 - 31.01.2012)
- Ford, William
To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01.09.2008 - 31.03.2010)
- Hutcheson, Iain
An assessment using conventional polymer moulding techniques, of sugars, cyclodextrins and natural polyerms for biodegradable microneedle applications (01.10.2008 - 01.07.2012)
- Birchall, James
Anticancer drug discovery (01.10.2008 - 01.06.2010)
- Mcguigan, Christopher
Discover antiviral carbohydrate binding agents (01.10.2008 - 31.12.2013)
- Mcguigan, Christopher
A real time, stand alone, portable detector for Bacillus anthracis spores (01.01.2009 - 01.04.2009)
- Baillie, Les
Pulmonary pharmacokientics of antimicrobial peptides (12.01.2009 - 12.01.2010)
- Gumbleton, Mark
Meeting - Preservatives in gaviscon formulations (26.01.2009 - 10.02.2010)
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01.03.2009 - 13.01.2010)
- Maillard, Jean-Yves
Evaluation of rapid microbial detection methods to improve the quality assurance release process for NHS aseptic manufactured products (02.03.2009 - 25.12.2009)
- Maillard, Jean-Yves
Consultancy to advise on the analysis of anthelminthic drug when co-formulated with nutritional supplements (16.03.2009 - 16.06.2009)
- Allender, Christopher
Biomaterials and biological interfaces: Towards optimising drug gene delivery (01.04.2009 - 31.08.2010)
- Gumbleton, Mark
Combined use of AZD0530 and fulvestrant in breast cancer (01.04.2009 - 31.03.2010)
- Hiscox, Stephen
Pilot markers study in breast cancer to assess treatment failure to targeted therapies (01.04.2009 - 31.03.2011)
Anti_CD44 antibody in breast cancer cell lines (01.05.2009 - 01.11.2009)
- Hutcheson, Iain
Investigation of mTOR inhibition using AZ5 in breast cancer models responsive and resistant to oestrogen deprivation in vitro (01.05.2009 - 31.12.2011)
- Gee, Julia
PHARMATRAIN - Pharmaceutical medicine training programmes (01.05.2009 - 30.04.2014)
Topical delivery of Melatonin Derivatives (01.06.2009 - 30.09.2009)
- Heard, Charles
Characterisation of the immune response to the AVP vaccine (01.07.2009 - 28.02.2010)
- Baillie, Les
Device testing (01.07.2009 - 31.05.2010)
- Birchall, James